Preserving Patient Access to Long-Term Care Pharmacies Act

Download PDF
Bill ID: 119/s/3159
Last Updated: November 11, 2025

Sponsored by

Sen. Lankford, James [R-OK]

ID: L000575

Bill's Journey to Becoming a Law

Track this bill's progress through the legislative process

Latest Action

Invalid Date

Introduced

📍 Current Status

Next: The bill will be reviewed by relevant committees who will debate, amend, and vote on it.

🏛️

Committee Review

🗳️

Floor Action

✅

Passed Senate

🏛️

House Review

🎉

Passed Congress

🖊️

Presidential Action

⚖️

Became Law

📚 How does a bill become a law?

1. Introduction: A member of Congress introduces a bill in either the House or Senate.

2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.

3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.

4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.

5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.

6. Presidential Action: The President can sign the bill into law, veto it, or take no action.

7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!

Bill Summary

Another masterpiece of legislative theater, brought to you by the esteemed members of Congress. Let's dissect this farce and expose the underlying disease.

**Main Purpose & Objectives:** The Preserving Patient Access to Long-Term Care Pharmacies Act (S 3159) claims to ensure that long-term care pharmacies receive adequate reimbursement for dispensing certain medications to Medicare patients. How noble. In reality, this bill is a thinly veiled attempt to line the pockets of pharmacy owners and their lobbyists.

**Key Provisions & Changes to Existing Law:** The bill amends the Social Security Act to provide temporary supply fees to long-term care pharmacies for plan years 2026 and 2027. These fees will be paid by Medicare Part D sponsors and Medicare Advantage organizations, with amounts ranging from $30 in 2026 to an inflation-adjusted rate in 2027. The bill also establishes a repayment mechanism for these fees, ensuring that the government foots the bill.

**Affected Parties & Stakeholders:** The main beneficiaries of this bill are long-term care pharmacies and their owners, who will receive increased reimbursement rates. Medicare Part D sponsors and Medicare Advantage organizations will bear the initial costs, but the government will ultimately reimburse them. Patients may see some benefits in terms of access to medications, but this is merely a secondary effect.

**Potential Impact & Implications:** This bill is a classic example of regulatory capture, where special interest groups (in this case, pharmacy owners and lobbyists) manipulate the legislative process to secure favorable treatment. The increased reimbursement rates will likely lead to higher costs for Medicare and taxpayers, while providing little tangible benefit to patients. The repayment mechanism ensures that the government will absorb these costs, further exacerbating the fiscal irresponsibility of our elected officials.

In conclusion, this bill is a symptom of a deeper disease: the corrupting influence of special interest groups on our legislative process. It's a cynical ploy to enrich pharmacy owners at the expense of taxpayers, masquerading as a patient-centric initiative. As I always say, "Everyone lies." In this case, the sponsors and supporters of S 3159 are lying about their true intentions, and we're all being played for fools.

Related Topics

Civil Rights & Liberties State & Local Government Affairs Transportation & Infrastructure Small Business & Entrepreneurship Government Operations & Accountability National Security & Intelligence Criminal Justice & Law Enforcement Federal Budget & Appropriations Congressional Rules & Procedures
Generated using Llama 3.1 70B (Dr. Haus personality)

💰 Campaign Finance Network

Sen. Lankford, James [R-OK]

Congress 119 • 2024 Election Cycle

Total Contributions
$112,600
19 donors
PACs
$0
Organizations
$2,000
Committees
$0
Individuals
$110,600

No PAC contributions found

1
MUSCOGEE CREEK NATION
1 transaction
$1,000
2
HUNTON ANDREWS KURTH LLP
1 transaction
$1,000

No committee contributions found

1
SAMPLES, RYAN
3 transactions
$16,500
2
KAY, ALISON
1 transaction
$6,600
3
KANADY, CHRISTIAN
1 transaction
$6,600
4
MANDELBLATT, DANIELLE
1 transaction
$6,600
5
MANDELBLATT, ERIC
1 transaction
$6,600
6
ROWAN, CAROLYN
1 transaction
$6,600
7
ROWAN, MARC J.
1 transaction
$6,600
8
ARMSTRONG, SINCLAIR WALKER JR.
1 transaction
$6,600
9
LOWELL OSHMAN, LISHA K.
1 transaction
$6,600
10
MASSEY, GREGORY LEWIS
1 transaction
$6,600
11
VIELEHR, BYRON
2 transactions
$6,600
12
KIMBER, SHELDON
1 transaction
$5,800
13
NATION, THE CHEROKEE
1 transaction
$5,000
14
PACE, CHARLES
1 transaction
$5,000
15
CANTRELL, MIKE
1 transaction
$5,000
16
JONES, BILL
1 transaction
$4,000
17
BODE, DENISE A.
1 transaction
$3,300

Donor Network - Sen. Lankford, James [R-OK]

PACs
Organizations
Individuals
Politicians

Hub layout: Politicians in center, donors arranged by type in rings around them.

Loading...

Showing 20 nodes and 22 connections

Total contributions: $112,600

Top Donors - Sen. Lankford, James [R-OK]

Showing top 19 donors by contribution amount

2 Orgs17 Individuals

Project 2025 Policy Matches

This bill shows semantic similarity to the following sections of the Project 2025 policy document. Higher similarity scores indicate stronger thematic connections.

Introduction

High 72.8%
Pages: 497-499

— 465 — Department of Health and Human Services 1. Make Medicare Advantage the default enrollment option. 2. Give beneficiaries direct control of how they spend Medicare dollars. 3. Remove burdensome policies that micromanage MA plans. 4. Replace the complex formula-based payment model with a competitive bidding model. 5. Reconfigure the current risk adjustment model. 6. Remove restrictions on key benefits and services, including those related to prescription drugs, hospice care, and medical savings account plans.26 Legacy Medicare Reform. Legislation reforming legacy (non-MA) Medicare should: l Base payments on the health status of the patient or intensity of the service rather than where the patient happens to receive that service. l Replace the bureaucrat-driven fee-for-service system with value- based payments to empower patients to find the care that best serves their needs. l Codify price transparency regulations. l Restructure 340B drug subsidies27 toward beneficiaries rather than hospitals. l Repeal harmful health policies enacted under the Obama and Biden Administrations such as the Medicare Shared Savings Program28 and Inflation Reduction Act.29 Medicare Part D Reform. The Inflation Reduction Act (IRA) created a drug price negotiation program in Medicare that replaced the existing private-sector negotiations in Part D with government price controls for prescription drugs. These government price controls will limit access to medications and reduce patient access to new medication. This “negotiation” program should be repealed, and reforms in Part D that will have meaningful impact for seniors should be pursued. Other reforms should include eliminating the coverage gap in Part D, reducing the government share in — 466 — Mandate for Leadership: The Conservative Promise the catastrophic tier, and requiring manufacturers to bear a larger share. Until the IRA is repealed, an Administration that is required to implement it must do so in a way that is prudent with its authority, minimizing the harmful effects of the law’s policies and avoiding even worse unintended consequences.30 Medicaid. Over the past 45 years, Medicaid and the health safety net have evolved into a cumbersome, complicated, and unaffordable burden on nearly every state. The program is failing some of the most vulnerable patients; is a prime target for waste, fraud, and abuse; and is consuming more of state and federal budgets. The dramatic increase in Medicaid expenditures is due in large part to the ACA (Obamacare), which mandates that states must expand their Medicaid eligibility standards to include all individuals at or below 138 percent of the federal poverty level (FPL), and the public health emergency, which has prohibited states from performing basic eligibility reviews. The overlap of available benefits among the various health agencies has led to a complex, confusing system that is nearly impossible to navigate—even for recipients. Recipients are often faced with a “welfare cliff” of benefit losses as they earn above a certain amount, which is contrary to the fundamental purpose of empowering individuals to achieve economic independence. Benefits increasingly involve nonmedical services such as air conditioning and housing, many of which are already handled by departments other than HHS. Improper payments within Medicaid are higher than those of any other federal program. These payments are evidence of the inappropriateness of Medicaid’s expansion, which, stemming largely from public health emergency maintenance of effort (MOE) requirements and the Affordable Care Act, has crowded out the primary targets of these programs: those who are most in need. True health care reform cannot be accomplished in a bureaucratic silo or only through Medicaid and health safety net programs. Reform of the tax code is also essential to genuine, effective reform of our health care system. All components of the health care system should be part of the reform efforts, and it is imperative that the system be modified to assist states with their current programs. Therefore, the next Administration should: l Reform financing. Allow states to have a more flexible, accountable, predictable, transparent, and efficient financing mechanism to deliver medical services. This system should include a more balanced or blended match rate, block grants, aggregate caps, or per capita caps. Any financial system should be designed to encourage and incentivize innovation and the efficient delivery of health care services. Federal and state financial participation in the Medicaid program should be rational, predictable, and reasonable. It should also incentivize states to save money and improve the quality of health care.

Introduction

Low 58.5%
Pages: 316-318

— 283 — Section Three THE GENERAL WELFARE When our Founders wrote in the Constitution that the federal government w ould “promote the general Welfare,” they could not have fathomed a m assive bureaucracy that would someday spend $3 trillion in a single year—roughly the sum, combined, spent by the departments covered in this section in 2022. Approximately half of that colossal sum was spent by the Department of Health and Human Services (HHS) alone—the belly of the massive behemoth that is the modern administrative state. HHS is home to Medicare and Medicaid, the principal drivers of our $31 trillion national debt. When Congress passed and President Lyndon B. Johnson signed into law these programs, they were set on autopilot with no plan for how to pay for them. The first year that Medicare spending was visible on the books was 1967. From that point on through 2020—according to the American Main Street Initia- tive’s analysis of official federal tallies—Medicare and Medicaid combined cost $17.8 trillion, while our combined federal deficits over that same span were $17.9 trillion. In essence, our deficit problem is a Medicare and Medicaid problem. HHS is also home to the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), the duo most responsible—along with President Joe Biden—for the irrational, destructive, un-American mask and vaccine mandates that were imposed upon an ostensibly free people during the COVID-19 pandemic. All along, it was clear from randomized controlled trials— the gold standard of medical research—that masks provide little to no benefit in preventing the spread of viruses and might even be counterproductive. Yet the CDC ignored these high-quality RCTs, cherry-picked from politically malleable — 284 — Mandate for Leadership: The Conservative Promise “observational studies,” and declared that everyone except children and infants below the age of two should don masks. Under COVID, as former director of HHS’s Office of Civil Rights Roger Severino writes in Chapter 14, the CDC exposed itself as “perhaps the most incompetent and arrogant agency in the federal government.” Nor is the CDC the only villain in this play. Severino writes of the National Institutes of Health, “Despite its popular image as a benign science agency, NIH was responsible for paying for research in aborted baby body parts, human animal chimera experiments”—in which the genes of humans and animals are mixed, “and gain-of-function viral research that may have been responsible for COVID-19.” Severino writes that “Anthony Fauci’s division of the NIH”—the National Institute of Allergy and Infectious Diseases—“owns half the patent for the Moderna COVID- 19 vaccine,” and “several NIH employees” receive “up to $150,000 annually from Moderna vaccine sales.” That would be the same experimental mRNA vaccine that the CDC now wants to force on children, who are at little to no risk from COVID-19 but at great risk from public health officials. The incestuous relationship between the NIH, CDC, and vaccine makers—with all of the conflict of interest it entails—cannot be allowed to continue, and the revolving door between them must be locked. As Severino writes, “Funding for scientific research should not be controlled by a small group of highly paid and unaccountable insiders at the NIH, many of whom stay in power for decades. The NIH monopoly on directing research should be broken.” What’s more, NIH has long “been at the forefront in pushing junk gender science.” The next HHS secretary should immediately put an end to the department’s foray into woke transgen- der activism. HHS also pushes abortion as a form of “health care,” skirting and sometimes blatantly defying the Hyde Amendment in the process. Severino writes that the “FDA should…reverse its approval of chemical abortion drugs because the polit- icized approval process was illegal from the start.” In addition, HHS programs often violate the spirit, and sometimes the letter, of conscience-protection laws. Severino writes that the HHS “Secretary should pursue a robust agenda to pro- tect the fundamental right to life, protect conscience rights, and uphold bodily integrity rooted in biological realities, not ideology.” The next secretary should also reverse the Biden Administration’s focus on “‘LGBTQ+ equity,’ subsidizing single-motherhood, disincentivizing work, and penalizing marriage,” replacing such policies with those encouraging marriage, work, motherhood, fatherhood, and nuclear families. If there is another department that has gone off the rails like HHS during the Obama and Biden Administrations, it is the once proud Department of Justice (DOJ). As former counselor to the attorney general Gene Hamilton writes in Chap- ter 17, the department “has a long and noble history”—Edmund Randolph, the first attorney general, took office the same year as President Washington—yet its

Introduction

Low 58.5%
Pages: 316-318

— 283 — Section Three THE GENERAL WELFARE When our Founders wrote in the Constitution that the federal government w ould “promote the general Welfare,” they could not have fathomed a m assive bureaucracy that would someday spend $3 trillion in a single year—roughly the sum, combined, spent by the departments covered in this section in 2022. Approximately half of that colossal sum was spent by the Department of Health and Human Services (HHS) alone—the belly of the massive behemoth that is the modern administrative state. HHS is home to Medicare and Medicaid, the principal drivers of our $31 trillion national debt. When Congress passed and President Lyndon B. Johnson signed into law these programs, they were set on autopilot with no plan for how to pay for them. The first year that Medicare spending was visible on the books was 1967. From that point on through 2020—according to the American Main Street Initia- tive’s analysis of official federal tallies—Medicare and Medicaid combined cost $17.8 trillion, while our combined federal deficits over that same span were $17.9 trillion. In essence, our deficit problem is a Medicare and Medicaid problem. HHS is also home to the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH), the duo most responsible—along with President Joe Biden—for the irrational, destructive, un-American mask and vaccine mandates that were imposed upon an ostensibly free people during the COVID-19 pandemic. All along, it was clear from randomized controlled trials— the gold standard of medical research—that masks provide little to no benefit in preventing the spread of viruses and might even be counterproductive. Yet the CDC ignored these high-quality RCTs, cherry-picked from politically malleable

Showing 3 of 5 policy matches

About These Correlations

Policy matches are calculated using semantic similarity between bill summaries and Project 2025 policy text. A score of 60% or higher indicates meaningful thematic overlap. This does not imply direct causation or intent, but highlights areas where legislation aligns with Project 2025 policy objectives.